Adherence and persistence to urate-lowering therapies in the Irish setting

Rates of adherence and persistence with allopurinol therapy among gout patients in Israel

(2013) G. Zandman-Goddard et al.   RHEUMATOLOGY

Prescription and dosing of urate-lowering therapy, rather than patient behaviours, are the key modifiable factors associated with targeting serum urate in gout

(2012) Nicola Dalbeth et al.   BMC MUSCULOSKELETAL DISORDERS

Gout. Epidemiology of gout

(2011) Edward Roddy et al.   ARTHRITIS RESEARCH & THERAPY

Using allopurinol above the dose based on creatinine clearance is effective and safe in patients with chronic gout, including those with renal impairment

(2010) Lisa K. Stamp et al.   ARTHRITIS AND RHEUMATISM

Adherence with urate-lowering therapies for the treatment of gout

(2009) Leslie R Harrold et al.   ARTHRITIS RESEARCH & THERAPY

Patient adherence and reimbursement amount for antidiabetic fixed-dose combination products compared with dual therapy among texas medicaid recipients

(2008) Chelim Cheong et al.   CLINICAL THERAPEUTICS

Comparison of Drug Adherence Rates Among Patients with Seven Different Medical Conditions

(2008) Becky A Briesacher et al.   PHARMACOTHERAPY

Medication Adherence of Patients with Selected Rheumatic Conditions: A Systematic Review of the Literature

(2008) Leslie R. Harrold et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM